Schedule 13G ownership disclosure

Mirna Therapeutics, Inc.

Security class unavailable · CUSIP: 60470J103

Event date: 2015-10-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,489,364
Percent of class
12.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-15-000040
Form type
SC 13G
Filer
SYNLOGIC, INC.
CIK
CIK 1527599
Filed
Oct 14, 2015
Reporting period
Oct 05, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub